Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells. 1988

E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

We report that IL 1 acts on the endothelium, inducing a long-lasting increase in its adhesivity to tumor cells. Selective pretreatment of cultured human umbilical vein endothelial cells (EC) with IL 1 caused a significant increase in adhesion of three human colorectal carcinoma (HT-29, HCC-P2988, and HCC-M1410) cell lines and one human melanoma (A-375) cell line. Tumor necrosis factor (TNF) was as effective as IL 1 in promoting tumor cell adhesion to EC, whereas IFN gamma and IL 2 were inactive. The IL 1 and TNF induction of EC adhesivity was both concentration (threshold concentration 1 U/ml) and time dependent (peak 4-6 h), reversible within 24 h, and blocked by a protein synthesis inhibitor. The IL 1 and TNF action on EC may play a role in tumor cell lodgement.

UI MeSH Term Description Entries
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
November 1991, Laboratory investigation; a journal of technical methods and pathology,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
December 1995, Blood,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
June 1991, The Journal of experimental medicine,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
November 1991, American journal of respiratory cell and molecular biology,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
February 2019, Environmental research,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
September 1990, Blood,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
August 1996, The Kobe journal of medical sciences,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
May 1991, Blood,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
November 2001, Investigative ophthalmology & visual science,
E Dejana, and F Bertocchi, and M C Bortolami, and A Regonesi, and A Tonta, and F Breviario, and R Giavazzi
December 1988, Cancer research,
Copied contents to your clipboard!